Table 2.
Treatment characteristics of the 897 incident RA by decade of index date
| Characteristic | 1980s | 1990s | 2000s |
|---|---|---|---|
| ESR at index, mm/hr, median (IQR) | 25 (31,40) | 20 (8,34) | 18 (9,32) |
| Max ESR first year, mm/hr, median (IQR) | 36 (20,50) | 27 (12,42) | 23 (12,40) |
| Methotrexate use in first year, N (%) | 4 (2) | 83 (28) | 233 (58) |
| Hydroxychloroquine use in first year, N (%) | 50 (25) | 133 (45) | 225 (56) |
| Other csDMARD use in first year, N (%) | 56 (28) | 44 (15) | 37 (9) |
| Biologic DMARD use, N (%) | 0 (0) | 1 (0) | 39 (9) |
cs = conventional synthetic, DMARD = disease-modifying anti-rheumatic drug, ESR = erythrocyte sedimentation rate, IQR = interquartile range, RA = rheumatoid arthritis